AddLife Financial Statements From 2010 to 2025
| ADDLFDelisted Stock | USD 42.00 0.00 0.00% |
Check AddLife AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AddLife AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . AddLife financial statements analysis is a perfect complement when working with AddLife AB Valuation or Volatility modules.
AddLife |
AddLife AB Company Shares Outstanding Analysis
AddLife AB's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current AddLife AB Shares Outstanding | 117.2 M |
Most of AddLife AB's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AddLife AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, AddLife AB has 117.2 M of shares currently outstending. This is 35.08% lower than that of the Healthcare sector and 36.44% higher than that of the Medical Instruments & Supplies industry. The shares outstanding for all United States stocks is 79.5% higher than that of the company.
AddLife AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AddLife AB's current stock value. Our valuation model uses many indicators to compare AddLife AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AddLife AB competition to find correlations between indicators driving AddLife AB's intrinsic value. More Info.AddLife AB is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.41 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for AddLife AB is roughly 2.44 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AddLife AB's earnings, one of the primary drivers of an investment's value.About AddLife AB Financial Statements
AddLife AB stakeholders use historical fundamental indicators, such as AddLife AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although AddLife AB investors may analyze each financial statement separately, they are all interrelated. For example, changes in AddLife AB's assets and liabilities are reflected in the revenues and expenses on AddLife AB's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AddLife AB. Please read more on our technical analysis and fundamental analysis pages.
AddLife AB , together with its subsidiaries, supplies equipment, instruments, and reagents to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries in Sweden, Finland, Denmark, Norway, and internationally. AddLife AB was founded in 1906 and is headquartered in Stockholm, Sweden. Addlife Ab operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 1778 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in AddLife Pink Sheet
If you are still planning to invest in AddLife AB check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AddLife AB's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |